News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • CVB Financial reported Q2 net earnings of $48.3 million, or $0.29 per share.
  • CVB completed the Heritage Commerce acquisition, expanding assets to $21.18 billion.
  • The acquisition drove significant loan and deposit growth.
  • Net interest margin rose to 3.72% despite acquisition expenses and provisions.
  • CVB announced a share repurchase program for up to 15 million shares.
  • Materialise trades at $6.50 and is recommended as a mid-term long targeting $8.00 with a $5.80 stop.

Latest Articles

INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study

INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study

INmune Bio announced peer-reviewed preclinical data demonstrating that XPro1595, their lead neuroinflammation drug candidate, selectively neutralizes soluble TNF and prevents brain-injury-induced amyloid pathology, cognitive deficits, and pain in an Alzheimer's disease mouse model. These findings, funded by the Department of Defense, elucidate the …

Aya Gold & Silver Advances Boumadine Project

Aya Gold & Silver Advances Boumadine Project

Aya Gold & Silver Inc. provides an update on its ongoing feasibility study and updated preliminary economic assessment for the Boumadine project, a large polymetallic mine in Morocco. The company has made significant progress on drilling, engineering, procurement, water and power infrastructure, metallurgical testwork, and logistics planning. Compe…

GXO To Host 2026 Investor Day

GXO To Host 2026 Investor Day

GXO Logistics, the largest pure-play contract logistics provider, will host its 2026 Investor Day on November 16 at the New York Stock Exchange. The event will include presentations from top management highlighting the company's long-term strategy, financial framework, and value creation opportunities. The event will be accessible both in-person an…

Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026

Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026

Tempest Therapeutics announced the advancement of its next-generation in vivo CAR-T platform, planning a first investigator-initiated clinical trial of its lead candidate TPST-4003 for nervous system autoimmune diseases like myasthenia gravis and multiple sclerosis. The trial aims to enroll about 10 patients with dosing expected in Q4 2026 and init…

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy

Axsome Therapeutics announced the FDA has accepted its New Drug Application for AXS-12, a treatment for cataplexy in narcolepsy, with a target action date under the PDUFA of May 1, 2027. The FDA currently does not plan an advisory committee meeting for this application. AXS-12 is a norepinephrine reuptake inhibitor aimed at improving wakefulness an…

BioCryst Appoints David W. Jenkins as Chief Scientific Officer

BioCryst Appoints David W. Jenkins as Chief Scientific Officer

BioCryst Pharmaceuticals has appointed David W. Jenkins as Chief Scientific Officer to lead an enhanced R&D strategy focused on external innovation and partnerships. Jenkins brings over 20 years of biopharmaceutical industry experience and will help accelerate development of rare disease therapies, building on BioCryst's marketed product ORLADEYO a…

Nuvini Appoints Rodrigo Natale as Chief Financial Officer

Nuvini Appoints Rodrigo Natale as Chief Financial Officer

Nuvini Group Limited, a Nasdaq-listed company specializing in acquiring and operating profitable B2B SaaS businesses in Latin America, has appointed Rodrigo Natale as its new Chief Financial Officer effective July 20, 2026. Mr. Natale brings nearly 30 years of financial leadership experience and is already a shareholder, aligning well with company …

Vusiongroup Shares Slide After AlphaValue Sell Call Questions VAS Margins

Vusiongroup Shares Slide After AlphaValue Sell Call Questions VAS Margins

Vusiongroup shares fell sharply after AlphaValue initiated coverage with a Sell rating, criticizing the company’s Value Added Services (VAS) segment margins and flagging cash, revenue, and customer-concentration risks. The stock dropped from an opening price of €132.2 to trade near €121.9, reaching an intraday low of €117.0 despite an operational u…

EU and Ukraine Agree to Joint Drone Production Initiative

EU and Ukraine Agree to Joint Drone Production Initiative

Ukraine and the European Union have reached an agreement to create joint projects that will combine Kyiv’s practical experience with European manufacturing scale to expand drone production. The deal, announced in Kyiv during Statehood Day remarks by European Commission President Ursula von der Leyen, is intended to coordinate efforts across EU memb…

Defence Minister’s Future in Flux as Zelenskiy Moves to Recast Cabinet

Defence Minister’s Future in Flux as Zelenskiy Moves to Recast Cabinet

President Volodymyr Zelenskiy’s planned cabinet overhaul has placed Defence Minister Mykhailo Fedorov under the spotlight. The 35-year-old former tech minister has pushed rapid reform in procurement, drone acquisition, and data-driven operations since his appointment six months ago. Uncertainty over his continued leadership risks unsettling a minis…

Elevance Health’s Insurance Margin Shock Sends Managed-Care Stocks Lower

Elevance Health’s Insurance Margin Shock Sends Managed-Care Stocks Lower

Elevance Health reported a steep year-over-year drop in operating margin for its Health Benefits unit in Q2 2026, triggering a broad premarket selloff across managed-care names despite a headline beat on revenue and adjusted earnings. While Elevance raised full-year adjusted EPS guidance, the core insurance business showed signs of margin stress, m…

Morgan Stanley Favors Edenred Over Pluxee Citing Cleaner Path to Recovery

Morgan Stanley Favors Edenred Over Pluxee Citing Cleaner Path to Recovery

Morgan Stanley raised its price target for Edenred SA to €34 from €33, signaling a 38% potential upside, and reduced its target for Pluxee N.V. to €15.50 from €21.00, implying 18% upside. The bank retained an overweight rating on Edenred and an equal-weight rating on Pluxee, calling Edenred its preferred exposure in the space due to a clearer recov…

M&T Bank Posts Higher Q2 Profit as Interest and Trust Income Climb

M&T Bank Posts Higher Q2 Profit as Interest and Trust Income Climb

M&T Bank reported higher net income for the second quarter, driven by growth in interest income and trust-related revenue. The bank recorded a wider net interest margin, increased loan balances, and a modest fall in provisions for credit losses, while mortgage banking revenue edged down. Net income available to common shareholders rose to $781 mil…

Vusion Shares Drop After AlphaValue Starts Coverage With Sell Call

Vusion Shares Drop After AlphaValue Starts Coverage With Sell Call

Shares of Vusion Group (EPA:VU) tumbled almost 8% on Monday following AlphaValue's initiation of coverage with a "sell" rating. The broker cited material cash and revenue risks, questioned the substance of Vusion's shift toward software Value Added Services (VAS), and flagged the company's heavy reliance on a single large Walmart (NYSE:WMT) contrac…

VCI Global Reports FY2025 Results, Highlighting Strategic Restructuring and Positioning for Long-Term Growth

VCI Global Reports FY2025 Results, Highlighting Strategic Restructuring and Positioning for Long-Term Growth

VCI Global reported a transformational FY2025 with US$26.1 million in revenue, a 6% decline YoY, driven by a 29% reduction in consultancy revenue partially offset by a 13.3% increase in technology solutions revenue. The company completed a strategic spin-off of its advisory arm (VCCG) and intensified investments in AI infrastructure, resulting in a…